Drug Delays Worsening of Newly Diagnosed Pulmonary Arterial Hypertension

(MedPage Today) — For recently diagnosed pulmonary arterial hypertension (PAH), adding sotatercept (Winrevair) to standard care lowered the risk of clinical worsening, the randomized HYPERION trial showed.
Among 320 patients, at least one primary…